Swiss All Share Index

Swiss All Share Index handeln
18.433,42 PKT -59,94 PKT -0,32 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
13.04.05 Logitech Neutral Sarasin Research
13.04.05 Lonza Reduce Sarasin Research
13.04.05 Novartis Neutral Sarasin Research
11.04.05 Barry Callebaut Neutral Helvea
11.04.05 Givaudan Equal weight Lehman Brothers
11.04.05 Richemont Buy Sarasin Research
11.04.05 Swiss Life Akkumulieren Nord LB
12.04.05 Adecco SA Sell Dresdner Kleinwort Wasserstein
11.04.05 Richemont Accumulate Helvea
11.04.05 Zurich Insurance Neutral JP Morgan
11.04.05 Sulzer Buy Sarasin Research
11.04.05 Lonza Overweight JP Morgan
11.04.05 Givaudan Neutral Helvea
11.04.05 Adecco SA Accumulate Helvea
11.04.05 Givaudan Underperform HypoVereinsbank
11.04.05 Givaudan Neutral Sarasin Research
08.04.05 Swiss Life Underperformer LB Rheinland-Pfalz
08.04.05 Novartis Accumulate Helvea
08.04.05 Zurich Insurance Accumulate Helvea
08.04.05 Givaudan Neutral Helvea
08.04.05 Swiss Life Neutral HypoVereinsbank
08.04.05 Zurich Insurance Sector Outperform Vontobel
12.04.05 Swiss Life Kaufen M.M. Warburg
08.04.05 Zurich Insurance Hold Dresdner Kleinwort Wasserstein
08.04.05 Helvetia Baloise Neutral Sal. Oppenheim
08.04.05 Swiss Prime Site Neutral Sarasin Research
07.04.05 Lonza Reduce Sarasin Research
07.04.05 Swiss Life Underperformer LB Rheinland-Pfalz
07.04.05 Helvetia Baloise Accumulate Helvea
07.04.05 Swiss Life Sell Merck Finck & Co
07.04.05 Swiss Life Buy M.M. Warburg
08.04.05 Swiss Life Underperform Credit Suisse First Boston
06.04.05 Roche Buy Helvea
11.04.05 Swatch (I) Kaufen NATIONAL-BANK
06.04.05 Helvetia Baloise Accumulate Helvea
06.04.05 Swiss Life Sell Merck Finck & Co
07.04.05 Swiss Life Neutral Sarasin Research
06.04.05 Swiss Life Accumulate Helvea
07.04.05 Swiss Life Overweight Lehman Brothers
06.04.05 Swiss Life Overweight JP Morgan